BCAX earnings: next report 2026-08-11, real EPS beat/miss history, analyst consensus Buy, P/E -10.06. Updated 2026-07-23.
Bicara Therapeutics Inc. Common Stock (BCAX) Research Hub
Bicara Therapeutics Inc. Common Stock (BCAX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 22.81 USD (-3.51%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.06, market cap 1.51B. This hub links to the full technical, earnings and options research available for BCAX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 22.81 USD (-3.51%) |
| 52-week range | 21.3 USD – 30.99 USD |
| Trend regime | Range |
| 14-day RSI | 28.9 (Oversold) |
| Trailing P/E | -10.06 |
| Market cap | 1.51B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for BCAX
Covered Call on BCAX: how it works, illustrative setup around the real 22.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BCAX: how it works, illustrative setup around the real 22.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BCAX: how it works, illustrative setup around the real 22.81 USD price, max profit/loss, breakeven and when to use it. Educational.
BCAX technical analysis: range, last 22.81 USD, RSI 28.9, 52w range 21.3 USD–30.99 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BCAX in?
Bicara Therapeutics Inc. Common Stock (BCAX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BCAX in an uptrend or downtrend?
As of 2026-09-11, BCAX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BCAX's trailing P/E ratio?
BCAX's trailing P/E is -10.06, with a market cap of 1.51B. See the earnings research page for full valuation detail.
When does BCAX next report earnings?
BCAX is next scheduled to report earnings on 2026-08-11, with a consensus EPS estimate of -0.81978 USD.